The makers of veverimer, a drug in development to treat metabolic acidosis associated with chronic kidney disease (CKD) and to slow progression of CKD, announced the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback